Michael Grote is a notable inventor based in Penzberg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antigen-antibody conjugates. With a total of 4 patents to his name, Grote's work has had a considerable impact on medical research and applications.

Latest Patents

One of his latest patents involves covalently linked antigen-antibody conjugates. This patent describes a conjugate that comprises an antigen and an antibody specifically designed to bind to that antigen. A covalent bond is formed between the antigen and an amino acid residue in the CDR2 of the antibody. The antibody includes a cysteine residue at amino acid position 53, according to Kabat, in the heavy chain CDR2, which enhances its functionality and potential applications.

Career Highlights

Throughout his career, Michael Grote has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in his field.

Collaborations

Michael Grote has collaborated with several esteemed professionals in his career. Among his notable coworkers are Ulrich Brinkmann and Guy Georges, who have also made significant contributions to the field of biotechnology.

Conclusion

Michael Grote's innovative work in the development of antigen-antibody conjugates showcases his expertise and dedication to advancing medical research. His contributions continue to influence the field and pave the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.